DD113218A1 - - Google Patents

Info

Publication number
DD113218A1
DD113218A1 DD179834A DD17983474A DD113218A1 DD 113218 A1 DD113218 A1 DD 113218A1 DD 179834 A DD179834 A DD 179834A DD 17983474 A DD17983474 A DD 17983474A DD 113218 A1 DD113218 A1 DD 113218A1
Authority
DD
German Democratic Republic
Application number
DD179834A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD113218A1 publication Critical patent/DD113218A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD179834A 1974-04-30 1974-07-10 DD113218A1 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU742016451A SU1140786A1 (ru) 1974-04-30 1974-04-30 Средство при угрожающем выкидыше,дисфункции ичников и гиперплазии эндометри

Publications (1)

Publication Number Publication Date
DD113218A1 true DD113218A1 (cg-RX-API-DMAC10.html) 1975-05-20

Family

ID=20582093

Family Applications (1)

Application Number Title Priority Date Filing Date
DD179834A DD113218A1 (cg-RX-API-DMAC10.html) 1974-04-30 1974-07-10

Country Status (5)

Country Link
CH (1) CH603687A5 (cg-RX-API-DMAC10.html)
DD (1) DD113218A1 (cg-RX-API-DMAC10.html)
DE (1) DE2433406B2 (cg-RX-API-DMAC10.html)
HU (1) HU170583B (cg-RX-API-DMAC10.html)
SU (1) SU1140786A1 (cg-RX-API-DMAC10.html)

Also Published As

Publication number Publication date
CH603687A5 (cg-RX-API-DMAC10.html) 1978-08-31
DE2433406B2 (de) 1977-03-03
DE2433406A1 (de) 1975-11-13
SU1140786A1 (ru) 1985-02-23
HU170583B (cg-RX-API-DMAC10.html) 1977-07-28

Similar Documents

Publication Publication Date Title
CS170662B1 (cg-RX-API-DMAC10.html)
CS169448B1 (cg-RX-API-DMAC10.html)
CS171977B1 (cg-RX-API-DMAC10.html)
CS166586B1 (cg-RX-API-DMAC10.html)
CS165421B1 (cg-RX-API-DMAC10.html)
CH590339A5 (cg-RX-API-DMAC10.html)
CH573829A5 (cg-RX-API-DMAC10.html)
BG21167A1 (cg-RX-API-DMAC10.html)
CH592396A5 (cg-RX-API-DMAC10.html)
DD117353A2 (cg-RX-API-DMAC10.html)
CH585393A5 (cg-RX-API-DMAC10.html)
CH578169A5 (cg-RX-API-DMAC10.html)
CH605777A5 (cg-RX-API-DMAC10.html)
DD109297A1 (cg-RX-API-DMAC10.html)
CH576873A5 (cg-RX-API-DMAC10.html)
CH603248A5 (cg-RX-API-DMAC10.html)
CH610915A5 (cg-RX-API-DMAC10.html)
CH602507A5 (cg-RX-API-DMAC10.html)
CH597572A5 (cg-RX-API-DMAC10.html)
CH585113A5 (cg-RX-API-DMAC10.html)
CH578013A5 (cg-RX-API-DMAC10.html)
CH591212A5 (cg-RX-API-DMAC10.html)
CH583071A5 (cg-RX-API-DMAC10.html)
CH599716A5 (cg-RX-API-DMAC10.html)
CH600427A5 (cg-RX-API-DMAC10.html)